SCHEMBL7203350

SCHEMBL7203350

N=C(NO)N(Br)N=C(c1ccccc1)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ IDO1 P14902 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ HDAC7 Q8WUI4 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ NCOR2 Q9Y618 1/20 0.35
▸ F2 P00734 1/20 0.33
▸ F10 P00742 1/20 0.33
▸ F12 P00748 1/20 0.33
▸ F7 P08709 1/20 0.33
▸ F3 P13726 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17093429 0.79 CTSL (0.42) HDAC3CA12CA1IDO1ALOX15
SCHEMBL10498731 0.63 ALDH1A1 (0.50) ALDH1A1HPGDGFERRECQLKMT2A
Bromide SCHEMBL7203345 0.63 ALDH1A1 (0.47) HDAC3CA12CA1IDO1ALOX15
Benzamidoxime SCHEMBL194059 0.62 HDAC8 (0.50) HDAC3CA12CA1IDO1ALOX15
SCHEMBL2481899 0.62 NPSR1 (0.46) HDAC3CA12CA1IDO1ALOX15
SCHEMBL4649406 0.62 MEN1 (0.50) ALOX15ALDH1A1HPGDGFERBLM
SCHEMBL2892980 0.61 TDP1 (0.46) HDAC3CA12CA1IDO1ALOX15
SCHEMBL12629713 0.61 ALDH1A1 (0.53) HDAC3CA12CA1IDO1ALOX15
Benzamidoxime SCHEMBL28112602 0.61 ALOX15 (0.48) HDAC3CA12CA1IDO1ALOX15
SCHEMBL752522 0.60 ALDH1A1 (0.41) CA12CA1CA9HSD17B10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6599943-B1 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase WAPHARM AB (SE) 2003-07-29 — — US disclosed
EP-1007025-A1 USE OF HYDROXYGUANIDINES Wa Pharm AB (SE) 2000-06-14 — — EP disclosed
WO-1998023267-A1 USE OF HYDROXYGUANIDINES WAPHARM AB (SE) 1998-06-04 — — WO disclosed
Send feedback